Early Day Motion·EDM 52

PHARMACEUTICAL AWARD

31 October 19912 Signatures

Motion Text

That this House recognises the important contribution of the United Kingdom pharmaceutical industry to the health of the nation; notes that the highest award within that industry is the Prix Galien, which is conferred annually on the product `judged to have made the most significant overall contribution to patient care in terms of efficacy, safety and innovation'; and congratulates AMGEN Roche on receiving the 1991 United Kingdom Prix Galien for their product Neupogen, which reduces neutropenia, a potentially life threatening consequence of chemotherapy in cancer patients.